CCI vs ERNA · P/E 40, rev $6.57B vs P/E 0.0, rev $582.0K
Crown Castle (CCI) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CCI and ERNA stock pages for the full models.
Not investment advice.